Jakub Tolar
,
Credentials
MD, PhD

Dean of Medical School, Vice President for Clinical Affairs
Biography

Bio

Jakub Tolar, MD, PhD is the Dean of the University of Minnesota Medical School and a Distinguished McKnight Professor in the Department of Pediatrics, Blood and Marrow Transplant & Cellular Therapy. He is also the Vice President for Clinical Affairs at the University of Minnesota, Board Chair for University of Minnesota Physicians and co-leader of M Health Fairview, the Joint Clinical Enterprise between the University of Minnesota Medical School, University of Minnesota Physicians and Fairview Health Services. An internationally recognized physician and researcher, Dr. Tolar is known for his care of patients with recessive dystrophic epidermolysis bullosa. His research is focused on using hematopoietic stem cell transplant as a treatment for rare genetic disorders. Originally from the Czech Republic, Dr. Tolar received his medical education (MD) in Prague at Charles University. In 1992, he came to the University of Minnesota, where he completed his PhD in Molecular, Cellular & Developmental Biology and Genetics.

Research Summary

Dr. Tolar's research focuses on finding new ways of treating children with lethal diseases - cancer, inborn errors of metabolism, and devastating genetic disorders - using stem cell transplantation. He is also looking for safer and more effective methods of repairing and using a patient's own cells in diseases such as epidermolysis bullosa, mucopolysaccharidosis type I (Hurler syndrome), Fanconi anemia, and dyskeratosis congenita. Additional research interests include: reducing the negative effects of stem cell transplantation (such as using mesenchymal stromal cells for graft-versus-host disease), creation and use of induced pluripotent stem cells, gene therapy using gene addition (with viral vectors and trasposons), or gene editing (with synthetic nucleases to repair genes).

Research Interests
Epidermolysis bullosa
Fanconi anemia
Dyskeratosis congenita
Hurler syndrome (MPS)
Gene Therapy

Clinical Summary

Blood and marrow transplantation; Gene therapy for correction of genetic diseases

Education

PhD, University of Minnesota
Major: Molecular, Cellular & Developmental Biology and Genetics
MD, Summa cum laude, Charles University 1st Medical School
Examination of Maturity, Summa cum laude, Na vitezne plani
Major: Biology

Fellowships, Residencies, and Visiting Engagements

Fellow, Fellowship
University of Minnesota Medical Center
Postdoctoral Fellow, Fellowship
University of Minnesota
Visiting Scientist, Visiting Scholar
Cambridge University

Licensures and Certifications

Minnesota Medical License,
Licensure/Certification Number: 42278
American Board of Pediatrics
Licensure/Certification Number: 071445
DEA registration,
American Sub Board of Pediatric Hematology/Oncology
Licensure/Certification Number: 001866

Honors and Recognition

Best Doctors in America
2017
Academy for Excellence in Health Research, University of Minnesota Academic Health Center
2016
Distinguished McKnight University Professorship
2015
Innovator in Translational Research Award, University of Minnesota Pediatric Faculty Recognition
2014
Edmund Wallace Tulloch and Anna Marie Tulloch Chair in Stem Cell Biology, Genetics and Genomics
2013
Leadership in Healthcare , “Change Agent” Award, Minnesota Business Magazine
2013
Rare Disease Research Hall of Fame, National Organization for Rare Disorders
2013
Mpls.St.Paul Magazine "Top Doctor"
2012
Albert D. and Eva J. Corniea Chair
2011
Butterfly Award, Children’s Cancer Research Fund
2009
Scientist Development Award, American Heart Association
2006
Elected Member, Society of Pediatric Research
2005
University Pediatrics Foundation Scholar
2005
Young Investigator Award, American Society of Clinical Oncology
2003
Masonic Dietz Family Award for Travel
2003
Margaret Kendrick Hostetter MD Award for Research in Pediatric Subspecialty Training , 1st place, The 17th Annual Pediatric Research, Education and Scholarship Symposium
2003
Bone Marrow Transplantation Award, Amy Strelzer Manasevit Scholars Program
2002
Travel Award for Abstract Presentation, National Cancer Institute
1995
Academic Achievement Award of the Chancellor, Charles University
1990

Professional Memberships

Hematology/Oncology Council
2017-2020
New York Academy of Sciences
2017-2018
Scientific Committee on Stem Cells and Regenerative Medicine
2012-2016
American Society of Gene & Cell Therapy
Children’s Oncology Group, Investigator
Society of Pediatric Research
American Society of Transplantation
European Society for Gene and Cell Therapy
St. John’s Dermatological Society
International Society for Stem Cell Research
American Society of Hematology
Pediatric Blood and Marrow Transplant Consortium
Non-Malignant Strategy Group, Volunteer Co-Leader
Stem Cell Therapy for Severe Inherited Skin Fragility Disorders Consortium
Society for Investigative Dermatology
Newborn Translational Research Network, SCID Working Group
Society for Hematology and Stem Cells
American Society of Pediatric Hematology/Oncology
American Society of Clinical Oncology
Cell Therapy Medical Tourism Committee
Zinc Finger Consortium
Pediatric Dermatology Research Alliance
American Society of Blood and Marrow Transplantation
European Hematology Association
American Academy of Pediatrics
American Heart Association, Council on Cardiovascular Disease in the Young

Languages

Czech
Selected Presentations

Selected Presentations

Tolar, J. "Stem cell gene therapy for genetic disorders", Keystone Symposium, Keystone, Colorado, February 13, 2018.
Tolar, J. "Cell-protein- and gene-based therapies for EB", World Congress of Pediatric Dermatology, Chicago, Illinois, July 06, 2017.
Tolar, J. "Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)", Society for Investigative Dermatology Annual Meeting, Portland, Oregon, April 28, 2017.
Tolar, J. "Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa", Medical Dermatology Society Meeting, Portland, Oregon, April 28, 2017.
Tolar, J. "Therapeutic DNA Repair: From Cloning to Clinic", New York Academy of Science, New York City, New York, April 11, 2017.
Tolar, J. "The Challenges of Informed Consent: Research with Children, Adolescents & Adults", University of Minnesota Research Ethics Conference, Minneapolis, Minnesota, March 08, 2017.
Patel, D., Patel, K., Tolar, J., Blazar, B. R. "High throughput proteome screening platform for HSC", 2017 Regenerative Medicine Minnesota, Mayo Clinic, Rochester, Minnesota, United States. January 01, 2017.
Kramarzova, K. S., Osborn, M., DeFeo, A., McElroy, A., Slamova, M., Tolar, J. "Gene editing in Fanconi Anemia: CRISPR/Cas9-mediated correction of FANCD1 gene in patient primary cells", 2017 American Society of Gene & Cell Annual Meeting, January 01, 2017.
Lee, C., Tolar, J., Azarin, S., Seo, H. "Path of least resistance: modeling the BBB of patients with x-ald using directed differentiation of human iPSCs into brain microvascular endothelial cells (BMECs)", International Society for Stem Cell Research 2017 Annual Meeting, January 01, 2017.
Vanden Oever, M., Muldoon, D., Tolar, J. "miR-29 regulates type VII collagen in individuals with recessive dystrophic epidermolysis bullosa (RDEB)", Rare Diseases Day, University of Minnesota, Minneapolis, Minnesota, United States. January 01, 2017.
Pickett-Leonard, M., Tolar, J. "Mechanisms of squamous cell carcinoma development in patients with recessive dystrophic epidermolysis bullosa", Rare Diseases Day, University of Minnesota, Minneapolis, Minnesota, United States. January 01, 2017.
Lee, C., Lees, C., Webber, B., Silverstein, K., Riddle, M., Xia, L., Tolar, J. "Leopard Spots on the Genome: A Case Study of RDEB Mosaicism", Rare Diseases Day, University of Minnesota, Minneapolis, Minnesota, United States. January 01, 2017.
Thompson, B., Tolar, J., Hendrickson, E. A. " Gene therapy for Fanconi anemia using CRISPR/Cas9-mediated gene targeting", Rare Diseases Day, University of Minnesota, Minneapolis, Minnesota, United States. January 01, 2017.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D. R., Riddle, M., Hook, K., Hordinsky, M., Marinkovich, M. P., Tryon, R., DeFor, T. E., Ebens, C. L., Tamai, K., Hovnanian, A., Blazer, B. R., Wagner, J. E. "Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB)", 2017 SID Annual Meeting, January 01, 2017.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D. R., Riddle, M., Hook, K., Hordinsky, M., Marinkovich, M. P., Woodley, D. T., Chen, M., Tryon, R., DeFor, T. E., Ebens, C. L., Tamai, K., Hovnanian, A., Blazer, B. R., Wagner, J. E. "Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)", 2017 Medical Dermatological Society Meeting, January 01, 2017.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D. R., Riddle, M., Hook, K., Hordinsky, M., Marinkovich, M. P., Woodley, D. T., Chen, M., Tryon, R., DeFor, T. E., Ebens, C. L., Tamai, K., Hovnanian, A., Blazer, B. R., Wagner, J. E. "Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)", 2017 SID Annual Meeting, January 01, 2017.
Tolar, J. "Hematopoietic Transplant in Epidermolysis Bullosa", IX Symposium of Epidermolysis Bullosa: Ninos Piel de Cristal, Santiago, Chile. December 15, 2016.
Tolar, J. "Gene Editing of COL7A1", IX Symposium of Epidermolysis Bullosa: Ninos Piel de Cristal, Santiago, Chile. December 15, 2016.
Tolar, J. "Best practices for effective collaboration", World Stem Cell Summit, West Palm Beach, Florida, December 08, 2016.
Tolar, J. "Gene edited stem cells: from cloning to clinic", European Society of Gene & Cell Therapy/International Society for Stem Cell Research Meeting, Florence, Italy. October 16, 2016.
Tolar, J. Regenerative Medicine Conference, Havana, Cuba. October 13, 2016.
Tolar, J. "Cell therapy for RDEB", European Epidermolysis Bullosa Meeting, Madrid, Spain. October 08, 2016.
Tolar, J. "Hematopoietic cell transplantation for RDEB", International Fanconi Anemia Gene Therapy Working Group Meeting, Madrid, Spain. October 07, 2016.
Tolar, J. "New Genes and Gene Therapy", Fanconi Anemia Research Symposium, Seattle, Washington, September 18, 2016.
Tolar, J. "Dyskeratosis Congenita-specific Bone Marrow Transplantation: Less Toxicity, Better Outcomes", Camp Sunshine, Portland, Maine, September 16, 2016.
Tolar, J. "Traditional stem cell transplant", Camp Sunshine, Portland, Maine, September 16, 2016.
Tolar, J. "Do no harm: Bone marrow transplant for severe generalized epidermolysis bullosa", Dystrophic Epidermolysis Bullosa Research Association of America Conference, Grapevine, Texas, July 26, 2016.
Tolar, J. "The worst disease you never heard of...and why it matters to you", TEDxFargo, Fargo, North Dakota, July 21, 2016.
Tolar, J. "From cloning to clinic: Regenerative medicine in Minnesota", Regenerative Medicine Minnesota 1st Annual Idea Exchange Celebration, Minneapolis, Minnesota, June 14, 2016.
Tolar, J. "How bone marrow transplantation changed my life with RDEB", St. John’s Annual Oration, St. John’s Dermatological Society, London, England. June 02, 2016.
Tolar, J. "Skin engraftment and type VII collagen (C7) expression after allogeneic hematopoietic cell transplantation (HCT) for generalized severe recessive dystrophic epidermolysis bullosa (RDEB)", 2016 Society for Investigative Dermatology meeting, Scottsdale, Arizona, May 13, 2016.
Tolar, J. "Efficient CRISPR/Cas9-mediated knockout of Col7a1 in NOD/SCID IL2Rgamma-null mice by pro-nuclear injection.” 2016 Society for Investigative Dermatology meeting", Scottsdale, Arizona, May 13, 2016.
Tolar, J. "Skin engraftment and type VII collagen (C7) expression after allogeneic hematopoietic cell transplantation (HCT) for generalized severe recessive dystrophic epidermolysis bullosa (RDEB)", 2016 Society for Investigative Dermatology Annual Meeting, Scottsdale, Arizona, May 11, 2016.
Tolar, J. "Dragon’s teeth: induced pluripotent stem cells to study germ cell tumors", University of Minnesota Germline Symposium, Minneapolis, Minnesota, May 10, 2016.
Tolar, J. "Systems: Stem cell biology", Boston Scientific, Minneapolis, Minnesota, May 06, 2016.
Tolar, J. "Regenerative Medicine: A necessary solution", CEO Roundtable Winsights Network, Minneapolis, Minnesota, May 06, 2016.
Tolar, J. "Epidermolysis Bullosa: The Worst Disease You Never Heard of", Third International Conference, How Science, Technology, Information and Communication Will Impact Society, Stem for Life Foundation and Pontifical Council for Culture, Vatican, Rome, Italy. April 25, 2016.
Tolar, J. "Severe recessive epidermolysis bullosa and stem cell transplantation", Epidermolysis Bullosa and Stem Cell Transplant Symposium, Great Ormond Street Hospital, London, England. April 05, 2016.
Tolar, J. "It is not rare—for you, for society and for science", Stem Cell Institute/Center for Orphan Disease Research Rare Disease Day Program, University of Minnesota, Minneapolis, Minnesota, March 11, 2016.
Downs, E., Osborn, M. J., McGrath, J. A., Hovnanian, A., Tamai, K., Tolar, J., Baldridge, A. "Gastrointestinal outcomes of recessive dystrophic epidermolysis bullosa after hematopoietic cell transplantation", Digestive Disease Week 2016, January 01, 2016.
Thompson, B., Tolar, J., Hendrickson, E. A. "FANCN hypomorphic mutation retains BRCA1 binding domain", 2016 ASH Annual Meeting & Exposition, January 01, 2016.
Long-Boyle, J., Ivaturi, V., Sambol, N., Chan, D., Stricherz, M., Jennissen, C., Orchard, P., Tolar, J., Pai, S., Horn, B., Cowan, M. J., Dvorak, C. C. "Plasma and intracellular pharmacokinetic (PK) analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients", 2016 BMT Tandem Meetings, January 01, 2016.
Thompson, B., Tolar, J., Hendrickson, E. A. "FANCN hypomorphic mutation retains BRCA1 binding domain", 2016 Fanconi Anemia Research Symposium., January 01, 2016.
Anderlini, P., Wu, J., Deeg, H. J., Gersten, I., Ewell, M., Tolar, J., Antin, J., Arai, S., Horwitz, M., McCarty, J., Nakamura, R., Pulsipher, M., Adams, R. H., Leifer, E., DiFronzo, N., Horowitz, M. H., Confer, D., Eapen, M. "Bone Marrow Transplant Clinical Trials Network. Cyclophosphamide (CY) conditioning in patients with severe aplastic anaemia (SAA) given unrelated marrow transplantation: Final results of a phase 1-2 dose de-escalation study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0301)", 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, January 01, 2016.
Jung, J., Lin, W., Tolar, J., Ogle, B. "Hydrogel platform for modeling the dermoepidermal junction in vitro.", Biomedical Engineering Society 2016 Annual Meeting, January 01, 2016.
Woska, E., Twaroski, K., Tolar, J. "Mechanisms of hematopoietic cell transplantation in recessive dystrophic epidermolysis bullosa patients", 2016 Life Sciences Summer Undergraduate Research Program Poster Symposium, January 01, 2016.
Vanden Oever, M. J., Muldoon, D., Tolar, J. "miR-29 regulates type VII collagen in individuals with recessive dystrophic epidermolysis bullosa (RDEB)", 75th Annual Society for Investigative Dermatology Meeting, January 01, 2016.
Webber, B., O’Connor, K., McElmurry, R. T., Durgin, E. N., Riddle, M. J., Osborn, M. J., Tolar, J. "Efficient CRISPR/Cas9-mediated knockout of Col7a1 in NOD/SCID IL2Rgamma-null mice by pro-nuclear injection", 75th Annual Society for Investigative Dermatology Meeting, January 01, 2016.
Osborn, M., Webber, B., McElroy, A., Defeo, A., Patel, D., Lees, C., McElmurry, R., Riddle, M., Blazar, B., Tolar, J. "CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa (RDEB)", 75th Annual Society for Investigative Dermatology Meeting, January 01, 2016.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D., Hook, K., Hordinsky, M. K., Marinkovich, P., Woodley, D., et al. "Skin engraftment and type VII collagen (C7) expression after allogeneic hematopoietic cell transplantation (HCT) for generalized severe recessive dystrophic epidermolysis bullosa (RDEB)", 75th Annual Society for Investigative Dermatology Meeting, January 01, 2016.
Mallhi, K., Ebens, C. L., Tolar, J., Miller, W. P., Orchard, P. J., Lund, T. C. "Second allogeneic hematopoietic cell transplant for graft failure in non-malignant patients: high rate of engraftment with low-dose busulfan, fludarabine, low-dose total body irradiation conditioning", 2016 BMT Tandem Meetings, January 01, 2016.
Lee, C., Azarin, S., Tolar, J. "Modeling the blood-brain barrier of adrenoleukodystrophy (X-ALD) patients using directed differentiation of human iPSCs into brain microvascular endothelial cells (BMECS)", International Society for Stem Cell Research (ISSCR) Annual Meeting 2016, January 01, 2016.
Osborn, M. J., Gabriel, R., Webber, B. R., DeFeo, A. P., McElroy, A. N., Jarjour, J., Starker, C. G., Wagner, J. E., Joung, J. K., Voytas, D. F., von Kalle, C., Schmidt, M., Blazar, B. R., Sharma, V., Ahn, M. J., Miller, T. J., Tolar, J. "CRISPR/Cas9 as a promising gene editing tool for Fanconi anemia treatment", 2nd CRISPR Congress, January 01, 2016.
Downs, E., Osborn, M. J., McGrath, J. A., Hovnanian, A., Katsuto, T., Wagner, J., Tolar, J., Baldridge, A. D. "Gastrointestinal outcomes of recessive dystrophic epidermolysis bullosa after hematopoietic cell transplantation", Digestive Disease Week 2016, January 01, 2016.
Lee, C., Lees, C., Webber, B., Silverstein, K., Riddle, M., Xia, L., Tolar, J. "Leopard Spots on the genome: A case study of RDEB mosaicism", 2016 Minnesota Supercomputing Institute Research Exhibition, January 01, 2016.
Tolar, J. "Gene, Cell and Tissue Engineering for Regenerative Medicine", AMIT Award Program, Seoul, Korea, Republic of. November 20, 2015.
Tolar, J. "Bone Marrow Stem Cells to Treat Epidermolysis Bullosa", Montagna Symposium on the Biology of Skin, Salishan, Oregon, October 18, 2015.
Tolar, J. "Three Body Problem of Cell and Gene Therapy for Epidermolysis Bullosa", ESPD Summer School, European Society of Pediatric Dermatology, Lausanne, Switzerland. June 26, 2015.
Tolar, J. "Dyskeratosis Congenita. Disease-specific Bone Marrow Transplantation: Less toxicity, better outcomes", Academy for Clinical Laboratory Physicians and Scientists, Minneapolis, Minnesota, May 30, 2015.
Tolar, J. "Hope that the Road Is a Long One", Mayo Clinic Research Fellows Association, Rochester, Minnesota, May 21, 2015.
Tolar, J. "Pre-transplant Conditioning for RDEB: Less is more", Society for Investigative Dermatology Meeting, Atlanta, Georgia, May 07, 2015.
Tolar, J. "RDEB: Bone marrow transplantation & corneal fragility", DebRA Patient Care Conference, Atlanta, Georgia, May 06, 2015.
Tolar, J. "Regenerative Medicine: From ideas to clinical practice", Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic. April 29, 2015.
Tolar, J. "If You Think Research Is Expensive, Try Disease", Stem Cell Institute/Center for Orphan Disease Research Rare Disease Day Program, University of Minnesota, Minneapolis, Minnesota, February 26, 2015.
Tolar, J. "From Marrow to Matrix", Grand Rounds, Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University, Indianapolis, Indiana, January 08, 2015.
Biewen, C., Smith, A. R., Tolar, J., Miller, W. P. "Outcomes after donor lymphocyte infusion for insufficient donor chimerism following hematopoietic cell transplantation for non-malignant disorders", 57th Annual ASH Meeting and Exposition, January 01, 2015.
Knipping, F., Petri, K., Ruggiero, E., Osborn, M. J., Tolar, J., von Kalle, C., Schmidt, M., Gabriel, R. "Modification of TCR specificity by TALEN and CRISPR", 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), January 01, 2015.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D. R., Hook, K., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Hematopoietic cell transplantation (HCT) for recessive dystrophic epidermolysis bullosa (RDEB): Reduced intensity conditioning (RIC) has a better outcome than myeloablative conditioning (MAC).", 74th Annual Society for Investigative Dermatology Meeting, January 01, 2015.
Osborn, M. J., Webber, B. R., Knipping, F., Lonetree, C., DeFeo, A., McElroy, A., Starker, C., Gabriel, R., Merkel, S., Hippen, K. L., Voytas, D., von Kalle, C., Schmidt , M., Miller, J. S., Jarjour, J., Astrakhan, A., Scharenberg, A. M., Tolar, J., Blazar, B. R. "Megatal, CRISPR/Cas9, and TALEN T-cell receptor gene editing", 57th ASH Annual Meeting and Exposition, January 01, 2015.
Miller, J. S., Felice, M., McElmurry, R., McCullar, V., Zhou, X., Tolar, J., Schmohl, J. U., Panoskaltsis-Mortari, A., Zhang, B., Taras, E., Verneris, M. R., Cooley, S., Weisdorf, D. J., Blazar, B. R., Vallera, D. "Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion", 57th ASH Annual Meeting and Exposition, January 01, 2015.
Tolar, J., McGrath, J. A., Osborn, M. J., Keene, D. R., Hook, K., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Mucocutaneous engraftment and type VII collagen (C7) replacement after allogeneic hematopoietic cell transplantation (HCT) in patients with recessive dystrophic epidermolysis bullosa (RDEB)", 57th ASH Annual Meeting and Exposition, January 01, 2015.
Thompson, E., Tolar, J., Hendrickson, E. A. "Gene therapy for FANCN using CRISPR/Cas9-mediated gene targeting", Annual Fanconi Anemia Research Fund Scientific Symposium, January 01, 2015.
Caballero León, P. G., Tolar, J. "The role of matrix metalloproteinases in the outcome of bone marrow transplant for junctional epidermolysis bullosa", 15th Annual Biomedical Research Conference for Minority Students (ABRCMS), January 01, 2015.
Webber, B. R., Tolar, J., Kyba, M., Blazar, B. R. "Targeted single copy Runx1 reporter lines for interrogation and enhancement of definitive hematopoiesis from murine pluripotent stem cells", 44th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH), Kyoto, Japan. January 01, 2015.
Decanini, A., Tokarev, J., Eisengart, J., Shapiro, E., Summers, C. G., Orchard, P., Tolar, J., Bothun, E. D. "Ocular outcomes of combination enzyme replacement therapy with hematopoietic cell transplantation in Hurler syndrome", Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), January 01, 2015.
Lund, T. C., Leigel, J., Orchard, P., Cao, Q., Tolar, J., Brunstein, C. G., Wagner, J. E., Verneris, M. R., Weisdorf, D. J. "Second allogeneic hematopoietic cell transplantation for graft failure: Poorer outcomes for neutropenic graft failure", 2015 BMT Tandem Meetings, January 01, 2015.
Petrof, G., Lwin, S. M., Martinez-Quiepo, M., Abdul-Wahab, A., Tso, S., Mellerio, J., Slapen-Cortenbach, I., Boelens, J. J., Tolar, J., Veys, P., Kadiyirire, T., Ofuya, M., Peacock, J. L., Martinez, A., McGrath, J. "Allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa: An open-label, phase 1, single-centre trial.", 74th Annual Society for Investigative Dermatology Meeting, January 01, 2015.
Lim, S. K., Lai, R. C., Yeo, R., Tan, S. S., Choo, A., Tolar, J. "Mesenchymal stem cell EVs modulate cell adhesion homeostasis through its proteome", International Society for Extracellular Vesicles, January 01, 2015.
Knipping, Petri, Ruggiero, Osborn, Tolar, J., von Kalle, Schmidt, Gabriel "TCR modification by highly specific TALEN and CRISPR", Collaborative Congress of the European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT), January 01, 2015.
Pope, E., Bruckner, A., Lara-Corrales, I., Tolar, J., Lucky, A., Feinstein, J. "Validation of iscorEB (instrument for scoring clinical outcome for research of Epidermolysis Bullosa)", 2015 EB Research Symposium, January 01, 2015.
Fioredda, F., Korthof, L., Iacobelli, S., Knol, C., Ziagkos, D., Tolar, J., van Biezen, A., Socie, G., Veys, P., Aljurf, M., Or, R., de la Fuente, J., Bacigalupo, A., Fagioli, A., Fisher, F., Codina, J., Zecca, M., Ghavamzadeh, A., O’Brien, T., Smith, O., Dufour, C. "Preliminary data on the outcome of bone marrow transplantation in congenital diskeratosis. An analysis from the European Group for Bone Marrow Transplantation (EBMT)", 20th Congress of European Hematology Association, January 01, 2015.
Fioredda, F., Korthol, L., Iacobelli, S., Knol, C., Ziagkos, D., Tolar, J., van Biezen, A., Socie, G., Veys, P., Aljurf, M., Or, R., de la Fuente, J., Bacigalupo, A., Fisher, F., Fagioli, A., Codina, J., Zecca, M., Ghavamzadeh, A., O’Brien, T., Smith, O., Dufour, C. "Outcome of bone marrow transplantation in diskeratosis congenita: Preliminary data from the European Group for Bone Marrow Transplantation", 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, January 01, 2015.
Pope, E., Bruckner, A., Lara-Corrales, I., Tolar, J., Lucky, A., Feinstein, J. "Validation of iscorEB (instrument for scoring clinical outcome for research of Epidermolysis Bullosa", 2015 debra International Research Symposium, January 01, 2015.
Watt, S., Dayal, J., Wright, S., Pourreyron, C., McMillan, J., Riddle, M., McLean, I., Leigh, I., McGrath, J., Salas-Alanis, J., Tolar, J., South, A. P. "Lysyl hydroxylase 3 localizes to epidermal basement membrane and is reduced in patients with recessive dystrophic epidermolysis bullosa", 74th Annual Society for Investigative Dermatology Meeting, January 01, 2015.
Vanden Oever, M., Hedstrom, C., Tolar, J. "Chemotherapy used in conditioning regimen for hematopoietic stem cell transplantation in children with recessive dystrophic epidermolysis bullosa (RDEB) alters expression of type VII collagen", 12th Annual Meeting of the International Society for Stem Cell Research (ISSCR), January 01, 2015.
Tolar, J. "Gene Editing for Systemic Therapy of Recessive Dystrophic Epidermolysis Bullosa", VIII Symposium Epidermolysis Bullosa, DebRA International, Santiago, Chile. December 05, 2014.
Tolar, J. "Blood and Marrow Transplantation for Severe Recessive Dystrophic Epidermolysis Bullosa", VIII Symposium Epidermolysis Bullosa, DebRA International, Santiago, Chile. December 05, 2014.
Tolar, J. "Reaching For the Stars: The promise of stem cells and the future of regenerative medicine", Mentor Connection Program, Plymouth District Services Center, Plymouth, Minnesota, December 01, 2014.
Tolar, J. "Update", Lindhal Innovations Fund Awards, University of Minnesota, Minneapolis, Minnesota, November 20, 2014.
Tolar, J. "Patience and Fortitude", Jackson Gabriel Silver Benefit, New York, New York, November 06, 2014.
Tolar, J. "Cellular and Subcellular Therapy for Extracellular Matrix Disorders", A*STAR, Singapore. November 03, 2014.
Tolar, J. "Using Stem Cell Biology to Change the Practice of Medicine", John B. Coleman Lecture Series, St. Paul, Minnesota, October 29, 2014.
Tolar, J. "Gene Therapy for Fanconi Anemia: International platform", International Fanconi Anemia Gene Therapy Working Group, Milan, Italy. October 16, 2014.
Tolar, J. "Legacy of the Department of Pediatrics – Cell Therapies", Golden Cane Ceremony, McNamara Alumni Center, Minneapolis, October 06, 2014.
Tolar, J. Epidermolysis Bullosa Family Panel Q&A, UCLA, Los Angeles, California, September 21, 2014.
Tolar, J. "Fanconi Anemia Therapeutics: Past, present, and future", Fanconi Anemia Research Fund, Washington, District of Columbia, September 19, 2014.
Tolar, J. "Reject Complacency", Report to the Board of Regents, University of Minnesota, Minneapolis, Minnesota, September 12, 2014.
Tolar, J. Epidermolysis Bullosa Scoring System (iscorEB) validation meeting, presentation, and clinic, Denver, Colorado, August 23, 2014.
Tolar, J. "Blood and Marrow Transplantation for Severe EB", DebRA US Patient Care Conference, Nashville, Tennessee, July 30, 2014.
Tolar, J. "Stem Cell Gene Therapy for Fatal Genodermatosis", Regeneration: Recycle, Reuse & Renew, MinnCResT Summer Symposium, Minneapolis, Minnesota, July 16, 2014.
Tolar, J. "Gene Therapy for Human Disease: From ideas to clinical practice", Institute of Klinical and Experimental Medicine (IKEM), Prague, Czech Republic. June 26, 2014.
Tolar, J. "DC-Specific Bone Marrow Transplantation: Less toxicity, better outcomes", Short Telomere Syndrome Conference, Sydney, Australia. June 18, 2014.
Tolar, J. "Regenerative Medicine at the University of Minnesota", Report to the Board of Regents, University of Minnesota, Minneapolis, June 12, 2014.
Tolar, J. "EB Scoring System", iscorEB Meeting, Toronto, Canada. June 06, 2014.
Tolar, J. "Cell Regeneration: How Human Cells are Becoming Insulin-Producing Islet Cells", University of Minnesota Foundation Spotlight on Diabetes, Minneapolis, Minnesota, May 29, 2014.
Tolar, J. "Molecular Surgery for Fanconi Anemia", University of Minnesota and Mayo Joint Showcase, Minneapolis, Minnesota, May 20, 2014.
Tolar, J. "Stem Cell Therapy for MPS I - Hurler Syndrome", Future Directions in MPS I Symposium, Washington, District of Columbia, May 20, 2014.
Tolar, J. "Stem Cell Therapy for MPS I-Hurler", University of Minnesota Foundation, Wayzata, Minnesota, May 20, 2014.
Tolar, J. "Understanding Your Genome", University of Minnesota, Minneapolis, Minnesota, May 19, 2014.
Tolar, J. "Ideal and Support: Secret sauce", Winefest, Children’s Cancer Research Fund, Minneapolis, Minnesota, May 10, 2014.
Tolar, J. "UMN Regenerative Medicine: From ideas to clinical practice", Report to the Board of Regents, University of Minnesota, Minneapolis, Minnesota, May 08, 2014.
Tolar, J. "Rare Diseases – Academia, Industry, Patients & Support Groups", Rare Disease Day, Minneapolis, Minnesota, February 27, 2014.
Tolar, J. "2020 Vision for Regenerative Medicine", Stem Cell Institute presentation to the Fox & Hounds Group, University of Minnesota, Minneapolis, Minnesota, February 26, 2014.
Tolar, J. "Stem Cell Expansion for Bone Marrow Failure Syndromes", Novartis, San Diego, California, February 19, 2014.
Tolar, J. "Cellular Therapy: Concepts and plans", Osaka, Japan. February 14, 2014.
Tolar, J. "The Creative Destruction of Genes", Stem Cell Institute Weekly Research Seminar, University of Minnesota, Minneapolis, Minnesota, January 29, 2014.
Tolar, J. "Regeneration of the Stem Cell Institute", Research Finance Group, University of Minnesota, Minneapolis, Minnesota, January 29, 2014.
Tolar, J. "Gene Therapy Working Group Update", Annual Planning Meeting, Fanconi Anemia Research Fund, Portland, Oregon, January 24, 2014.
Tolar, J. "Reaching for the Stars: The promise of stem cells and the future of regenerative medicine", University of Minnesota MinneCollege, Naples, Florida, January 18, 2014.
Ross, J. A., Tolar, J., Spector, L. G., Defor, T. E., Lund, T. C., Weisdorf, D. J., Hooten, A. J., Thyagarajan, B., Langer, E., Gleason, M. K., Wagner, J. E., Robien, K., Verneris, M. R. "Mitochondrial haplotype as an independent predictor of outcomes following allogeneic hematopoietic cell transplantation (HCT)", 56th ASH Annual Meeting and Exposition, January 01, 2014.
Anderlini, P., Wu, J., Deeg, H. J., Gersten, I., Ewell, M., Tolar, J., Antin, J. H., Arai, S., Horwitz, M. E., McCarty, J. M., Nakamura, R., Pulsipher, M. A., Adams, R. H., Leifer, E., Carter, S. L., DiFronzo, N. L., Horowitz, M. M., Confer, D. L., Eapen, M. "Optimized cyclophosphamide (CY) dosing in combination with fludarabine, TBI and ATG as conditioning for unrelated donor bone marrow transplantation (BMT) in severe aplastic anemia (SAA): A Phase I/II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)", 56th ASH Annual Meeting and Exposition, January 01, 2014.
Xia, L., Keirstead, S., Eide, C., Tolar, J. "Biopacemaker cells and 2-dimensional cardiac tissue sheet derived from human induced pluripotent stem cells", Heart Rhythm 2014, January 01, 2014.
Sajic, D., Hook, K., Tolar, J. "Toxic epidermal necrolysis (TEN) in recessive dystrophic epidermolysis bullosa status post hematopoietic stem cell transplant", 89th Canadian Dermatology Association Annual Conference, January 01, 2014.
Long-Boyle, J., Sambol, N., Dvorak, C. C., Cowan, M. J., Lee, S., Huang, L. S., Horn, B., Stricherz, M., Tolar, J., Orchard, P., Jacobson, P., Aweeka, F. "Plasma and intracellular population pharmacokinetic analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients", 2014 BMT Tandem Meetings, January 01, 2014.
Belur, L., Nan, Z. H., Buckvold, M., Karlen, A., Kitto, K., Pedersen, K. M., Fairbanks, C., Hanson, L., Tolar, J., Kozarsky, K., Frey, W. H., Low, W. C., McIvor, R. S. "High level expression of human iduronidase throughout the brain in a murine model of mucopolysaccharidosis type I after non-invasive AAV-mediated gene deliver to the CNS", 17th Annual Meeting of the American Society of Gene and Cell Therapy (ASCGT), January 01, 2014.
Aldenhoven, M., Orchard, P., Kurtzberg, J., Wynn, R., O'Meara, A., Veys, P., Fischer, A., Valayannopoulos, V., Neven, B., Rovelli, A., Prasad, V. K., Tolar, J., Shapiro, E., Jones, S., Parini, R., Renard, M., Bordon, V., Poe, M., de Koning, T., Wraith, E., Escolar, M., Boelens, J. J. "Predictors of long-term clinical outcome in Hurler syndrome patients after successful hematopoietic cell transplantation: An international study", 2014 BMT Tandem Meetings, January 01, 2014.
Venhuizen, S., Lindborg, B., Haider, K., Ulrich, C., Vegoe, A., Subramaniam, S., Brekke, J. H., Dutton, J., Tolar, J., O’Brien, T. D. "Effects of vitronectin on neural differentiation and proliferation of human iPSC’s in 3D cell culture", Cornell University 25th Annual Merial-NIH Veterinary Scholars Symposium, January 01, 2014.
Lund, T. C., Miller, W., Polgreen, L., Baso, L., Raymond, G., Tolar, J., Orchard, P. " Improvement in biomarkers after intrathecal iduronidase for children with MPS IH", Society of Inherited Metabolic Disorders Annual Meeting, January 01, 2014.
Nan, Z. H., Buckvold, M., Karlen, A., Kitto, K., Podetz-Pedersen, K. M., Fairbanks, C., Hanson, L., Orhcard, P., Tolar, J., Frey, W. H., Low, W. C., McIvor, R. S., Belur, L. "High level expression of human iduronidase throughout the brain in a murine model of mucopolysaccharidosis type I (MSP I) after non-invasive AAV-mediated gene delivery to the CNS", ESGCT and NVGCT Collaborative Congress, January 01, 2014.
Tolar, J. "Adjacent Possible: Bone marrow cells in skin regeneration", UMR Connects Professional Speaker Series, University of Minnesota, Rochester, Rochester, Minnesota, December 17, 2013.
Tolar, J. "You Are Solving the Problems", Pioneering Unique Cures for Kids (PUCK) Breakfast Talk, Minneapolis, Minnesota, December 14, 2013.
Tolar, J. "Fatal Genodermatosis Epidermolysis Bullosa: Knowledge is therapy", Pediatric Grand Rounds, University of California, Los Angeles, California, November 21, 2013.
Tolar, J. "Gene and Cell Therapy in Regenerative Medicine", European Society of Gene and Cell Therapy and SETGyC Collaborative Congress, Madrid, Spain. October 26, 2013.
Tolar, J. "Inducible pluripotent stem cells", Cell-Based Therapies Symposia, Nationwide Children’s Hospital, Columbus, Ohio, October 14, 2013.
Tolar, J. "Treatment of Lethal Skin Diseases by Bone Marrow Transplantation: Murine models", Research Animal Resources, University of Minnesota, Minneapolis, Minnesota, October 02, 2013.
Tolar, J. "Fanconi anemia gene therapy: Where are we now? Where we go next?", International Fanconi Anemia Gene Therapy Working Group, Boston, Massachusetts, September 16, 2013.
Tolar, J. "Update on Epidermolysis Bullosa", International Working Group for Inborn Errors of Metabolism, Leiden, Netherlands. September 14, 2013.
Tolar, J. "Refining Hematopoietic Cell Transplantation in Dyskeratosis Congenita: Where now? And where next?", Telomeres and Disease,, Cold Spring Harbor Laboratory, New York, New York, September 10, 2013.
Tolar, J. "Blood and Marrow Transplant for Tissue Repair", Hematology-Oncology Research Conference seminar series, Case Western Reserve University, Cleveland, Ohio, August 07, 2013.
Tolar, J. "4th Age of Research", Stem Cell Institute presentation to the Czech Ambassador, University of Minnesota, Minneapolis, Minnesota, July 31, 2013.
Tolar, J. "Regenerative Medicine at the University of Minnesota", University of Minnesota Foundation Board of Overseers, Minneapolis, Minnesota, July 24, 2013.
Tolar, J. "Mission Adjacent Possible: School of Dentistry and the Stem Cell Institute", School of Dentistry, University of Minnesota, Minneapolis, Minnesota, July 09, 2013.
Tolar, J. "Two Strategies, One Goal: Cell and gene therapy for genodermatoses", Skin Center Research Grant Retreat, Denver, Colorado, June 29, 2013.
Tolar, J. "Translational Research in Genodermatoses", Shriners Research Center, Portland, Oregon, June 12, 2013.
Tolar, J. "Stem Cell Therapy for Epidermolysis Bullosa", Epithelial Differentiation and Keratinization Gordon Conference, Lucca, Italy. May 16, 2013.
Tolar, J. "-Genetics and pathogenetics", Society of Investigative Dermatology, Edinburgh, United Kingdom. May 10, 2013.
Tolar, J. "Bone Marrow Transplantation Has Better Outcomes than Umbilical Cord Blood Transplantation in Recessive Dystrophic Epidermolysis Bullosa", Society of Investigative Dermatology, Edinburgh, United Kingdom. May 09, 2013.
Tolar, J. "Rare Diseases and Common Disorders", Charles University Medical School, Prague, Czech Republic. April 26, 2013.
Tolar, J. "Blood to Skin: Transplantation and regenerative medicine", Charles University Medical School, Prague, Czech Republic. April 25, 2013.
Tolar, J. "Alternative Allografts in Bone Marrow Failure Syndromes Including SAA", First Annual Tandem ASPHO/PBMTC Educational Meeting, Miami, Florida, April 24, 2013.
Tolar, J. "Two Strategies, One Goal: Cell and gene therapy for epidermolysis bullosa", Stem Cell Institute Seminar, University of Minnesota, Minneapolis, April 17, 2013.
Tolar, J. "Seeing Regeneration: Opportunities for collaboration with the Stem Cell Institute", Spring Vision Symposium II: degeneration, regeneration and neuroprotection in the retina and brain, University of Minnesota, Minneapolis, April 12, 2013.
Tolar, J. "Novel Treatment Options for Fanconi Anemia", Fanconi Anemia Research Fund Scientific Advisory Board, Washington, District of Columbia, April 05, 2013.
Tolar, J. "Stem Cell Institute: Discovery, education and translation", Caffeinated Conversations, Center for Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, March 19, 2013.
Tolar, J. "Learning from a Paradox: Rare diseases for the masses", Rare Disease Day 2013 Special Seminar, Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, February 28, 2013.
Tolar, J. "Stem Cell Institute: Vision", University of Minnesota Foundation, Minneapolis., Minnesota, February 26, 2013.
Tolar, J. "Stem Cell Institute Vision and opportunities", Pharmacology Faculty, University of Minnesota, Minneapolis, Minnesota, February 22, 2013.
Tolar, J. "Bone Marrow Transplantation for Epidermolysis Bullosa", Local Metro Minnesota Association of Pediatric Hematology and Oncology Nurses Annual Conference,, Minneapolis, Minnesota, February 21, 2013.
Tolar, J. "Harnessing Stem Cell Gene Biology to Combat Genodermatoses", American Society for Blood and Marrow Transplantation/International Pachyonychia Congenita Project, Salt Lake City, Utah, February 14, 2013.
Tolar, J. "Icebreaker: Vision", Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, January 07, 2013.
Tolar, J., McGrath, J. A., Keene, D. R., Hook, K., Osborn, M. J., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Systemic cell therapy for epidermolysis bullosa: repair of skin extracellular matrix", ESGCT and NVGCT Collaborative Congress, January 01, 2013.
Tolar, J., McGrath, J. A., Keene, D. R., Hook, K., Osborn, M. J., Kavand, S., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Bone marrow transplantation has better outcomes than umbilical cord blood transplantation in recessive dystrophic epidermolysis bullosa (RDEB)", 72nd Annual Society of Investigative Dermatology Meeting, January 01, 2013.
Tolar, J., McGrath, J. A., Osborn, M. J., Hook, K., Keene, D. R., Hordinsky, M., Blazar, B. R., Wagner, J. E. "Bone marrow is the preferred graft for allogeneic hematopoietic stem cell transplantation in severe epidermolysis bullosa", 2013 BMT Tandem Meetings, January 01, 2013.
Tolar, J., McGrath, J. A., Keene, D. R., Hook, K., Osborn, M. J., Kavand, S., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Bone marrow transplantation has better outcomes than umbilical cord blood transplantation in recessive dystrophic epidermolysis bullosa (RDEB)", Minnesota Dermatological Society Annual Meeting, January 01, 2013.
Orchard, P., Cartier, N., Hacein-Bey-Abina, S., Kurtzberg, J., Escolar, M., Tolar, J., Baruchel, A., Dalle, J. H., Michel, G., Blanche, S., Bartholoma, C., Schmidt, M., Bougneres, P., Von Kalle, C., Cavazzana-Calvo, M., Fischer, A., Aubourg, P. "Hematopoietic stem cell gene therapy with lentiviral vector in 4 patients with cerebral X-linked adrenoleukodystrophy: long-term outcome and comparison of efficacy with allogeneic hematopoietic stem cell transplantation", ESGCT and NVGCT Collaborative Congress, January 01, 2013.
Braunlin, E., Miller, W. P., Tolar, J., Whitley, C. B., Orchard, P. "Cardiac findings in untreated infants <1 year of age with severe mucopolysaccharidosis (MPS) I", Lysosomal Disease Network's WORLD Symposium 2013, January 01, 2013.
Osborn, M. J., Starker, C. G., DeFeo, A. P., Voytas, D. F., Blazar, B. R., Tolar, J. "Transcription activator-like effector nuclease-based genome editing for mucopolysaccharidosis Type I", 16th Annual American Society of Cell and Gene Therapy, January 01, 2013.
Osborn, M. J., Starker, C. G., McElroy, A. N., Webber, B. R., Riddle, M. J., Xia, L., DeFeo, A. P., Gabriel, R., Schmidt, M., von Kalle, C., Carlson, D. F., Maeder, M. L., Joung, J. K., Wagner, J. E., Voytas, D. F., Blazar, B. R., Tolar, J. "TALEN-based individualized medicine for epidermolysis bullosa", 16th Annual American Society of Cell and Gene Therapy, January 01, 2013.
Cooksley, R. D., Ahmed, A., Shapiro, E., Orchard, P., Tolar, J., Whitley, C. B. "Genotyping analysis available for patients after hematopoietic cell transplantation for multiple types of lysosomal diseases", Lysosomal Disease Network's WORLD Symposium 2013, January 01, 2013.
Orchard, P., Cartier, N., Hacein-Bey-Abin, S., Kurtzberg, J., Escolar, M., Tolar, J., Baruchel, A., Dalle, J. H., Michel, G., Blanche, S., Bartholoma, C., Schmidt, M., Bougneres, P., van Kalle, C., Cavazzana-Calvo, M., Fischer, A., Aubourg, P. "Hematopoietic stem cell gene therapy with lentiviral vector in 4 patients with cerebral x-linked adrenoleukodystrophy: Long-term outcome and comparison of efficacy with allogeneic hematopoietic stem cell transplantation", 16th Annual American Society of Cell and Gene Therapy, January 01, 2013.
Modiano, J., Lindborg, B., Lewellen, M., McElmurry, R., Tolar, J., Zamora, E., Schaack, J., Bellgrau, D., O’Brien, T. "Mesenchym stem cells in the tumor immunosuppressive barrier", Keystone Symposia, January 01, 2013.
Tolar, J. "Problems Cannot Be Solved by the Same Level of Thinking that Created Them", Division of Epigenetics, University of Minnesota, Minneapolis, Minnesota, December 17, 2012.
Tolar, J. "Improving Hematopoietic Cell Transplantation in Epidermolysis Bullosa", American Society of Hematology Meeting, Atlanta, Georgia, December 06, 2012.
Tolar, J. "Transplantation for Bone Marrow Failures", 6th International Symposium on MDA and Bone Marrow Failure Syndromes in Childhood, Prague, Czech Republic. November 07, 2012.
Tolar, J. "Cell therapy – Induced Pluripotent Stem Cells", DebRA International Conference, Marbella, Spain. November 05, 2012.
Tolar, J. "Refining Bone Marrow Transplantation in EB: Where now? And where next?", DebRA International Conference, Marbella, Spain. November 05, 2012.
Tolar, J. "International Gene Therapy Trial for FA", International Fanconi Anemia Gene Therapy Working Group meeting, Versailles, France. October 25, 2012.
Tolar, J. "Gene Therapy for Fanconi Anemia", Fanconi Anemia Research Fund Family Meeting, Portland, Maine, October 13, 2012.
Tolar, J. "Can Stem Cells Cure Cutaneous Diseases?", Montagna Symposium on the Biology of the Skin, Salishan, Oregon, October 12, 2012.
Tolar, J. "The Pursuit of Stem Cell Expansion", Session Chair, Fanconi Anemia Research Fund Annual Meeting, Denver, Colorado, September 28, 2012.
Tolar, J. "counterpoint in the landscape of change", Session Chair, Fanconi Anemia Research Fund Annual Meeting, Denver, Colorado, September 28, 2012.
Tolar, J. "Hematopoietic Cells for Extracellular Matrix Deficiency", Stem Cell Institute Weekly Research Seminar, University of Minnesota, Minneapolis, Minnesota, September 26, 2012.
Tolar, J. "Bench to Bedside (and Back)", Mini Medical School, Academic Health Center, University of Minnesota, Minneapolis, Minnesota, September 25, 2012.
Tolar, J. "Role of iPSCs in EB", DEBRA International Conference, Toronto, Canada. September 15, 2012.
Tolar, J. "Stem Cell Therapy for Extracellular Matrix Disorders", DebRA of America 2012 Patient Care Conference, Orlando, Florida, July 31, 2012.
Tolar, J. "Hematopoietic Stem Cell Transplantation in Epidermolysis Bullosa", Nobel Conference on Hematopoietic Stem Cells: From Basic Science to Regenerative Medicine, Stockholm, Sweden. June 20, 2012.
Tolar, J. "Reinventing Blood and Marrow Transplant", Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, June 06, 2012.
Tolar, J. "Hematopoietic and Mesenchymal Cell Transplantation after Myeloablative And Non-Myeloablative Conditioning for Recessive Dystrophic And Junctional Epidermolysis Bullosa", Conjoint 3rd Australasian Wound & Tissue Repair Society and 9th Australasian Society for Dermatology Research Conference, Sydney, Australia. May 24, 2012.
Tolar, J. "Stem Cell Transplantation for the Therapy of Skin Diseases", American Society of Gene & Cell Therapy 15th Annual Meeting, Emerging Field Review Session, Philadelphia, Pennsylvania, May 16, 2012.
Tolar, J. "Personalized Induced Pluripotent Stem Cells for Optimizing EB Treatment", Society for Investigative Dermatology Meeting, Raleigh, North Carolina, May 11, 2012.
Tolar, J. "Stem Cells for Skin Diseases", International Pachyonchia Congenita Consortium Annual Meeting, Raleigh, North Carolina, May 09, 2012.
Tolar, J. "Stem Cell Transplantation for the Therapy of the Severe Epidermolysis Bullosa", International Meeting on Rare Diseases: Mechanisms and New Therapeutic Approaches, Freiburg, Germany. February 23, 2012.
Tolar, J. "Bone Marrow and Cord Blood for Treating Skin Collagen Deficiency in Epidermolysis Bullosa", Research Seminar, Institute of Child Health, London, United Kingdom. February 21, 2012.
Tolar, J. "Clinical Trial of Allogeneic Hematopoietic Transplantation for Rett Syndrome", New York, New York, February 18, 2012.
Tolar, J. "Hematopoietic Cells for Extracellular Matrix Deficiency", American Society for Blood and Marrow Transplantation Meeting, San Diego, California, February 05, 2012.
Tolar, J. "Bone Marrow is the Preferred Graft for Allogeneic HCT in Severe Epidermolysis Bullosa", American Society for Blood and Marrow Transplantation Meeting, Salt Lake City, Utah, February 05, 2012.
Tolar, J. "BMT for Genetic Diseases", Pediatric BMT/Hematology/Oncology Nursing Symposium 2012, Amplatz Children’s Hospital, Minneapolis, Minnesota, January 26, 2012.
Tolar, J. "Bone Marrow and Cord Blood for Treating Skin Collagen Deficiency in Epidermolysis Bullosa", Grand Rounds, University of Colorado, Denver, Colorado, January 19, 2012.
Tolar, J., McGrath, J. A., Keene, D. R., Hordinsky, M., Osborn, M. J., Riddle, M. J., Bertin, A. J., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Hematopoietic and mesenchymal stem cell transplantation for recessive dystrophic and junction epidermolysis bullosa", 72nd Society for Investigative Dermatology Meeting, January 01, 2012.
Osborn, M. J., Starker, C. G., DeFeo, A. P., Voytas, D. F., Wagner, J. E., Blazar, B. R., Tolar, J. "Transcription activator-like effector nuclease-based genome editing for Fanconi anemia (FA)", ESGCT/SFTCG Annual Congress 2012, January 01, 2012.
Cooksley, R. D., Shapiro, E., Orchard, P., Tolar, J., Whitley, C. B. "Buccal swab specimens for IDUA genotype analysis for patients after hematopoietic stem cell transplantation", Lysosomal Disease Network's WORLD Symposium 2012, January 01, 2012.
Felices, M., Lenvik, T., Ankarlo, D., Curtsinger, J., Tolar, J., Blazar, B. R., Anderson, S., Miller, J. S. "Education and cytokine receptor balance play a critical role in the long term survival of the most differentiated natural killer (NK) cells", 54th ASH Annual Meeting and Exposition, January 01, 2012.
Anderlini, P., Tolar, J., Deeg, H., Arai, S., Horwitz, M., Antin, J., McCarty, J., Adams, R., Ewell, M., Leifer, E., Gersten, I., Carter, S., Horowitz, M., Confer, D., Nakamura, R., Pulsipher, M., DiFronzo, N., Eapen, M. "Fludarabine-based conditioning for allogeneic marrow transplantation from unrelated donors in severe aplastic anaemia: serious and unexpected adverse events in pre-defined cyclophosphamide dose levels", 38th Annual European Society for Blood and Marrow Trnasplantation Meeting, January 01, 2012.
Lund, T. C., Verneris, M. R., Tolar, J., Cao, Q., Weisdorf, D. J., Wagner, J. E., Brunstein, C. G. "Encouraging survival for patients who had a second umbilical cord blood transplant for graft failure", 2012 BMT Tandem Meetings, January 01, 2012.
Tolar, J. "Optimal xenogeneic adoptive transfer of human NK cells: fresh NK cells and IL-15 administration are superior to frozen NK cells and IL-2", 54th ASH Annual Meeting and Exposition, January 01, 2012.
Tolar, J., McGrath, J. A., Osborn, M. J., Hook, K., Keene, D. R., Hordinsky, M., Blazar, B. R., Wagner, J. E. "Allogeneic hematopoietic cell transplantation for severe epidermolysis bullosa: impact of conditioning regimen and stem cell source on outcomes", 54th ASH Annual Meeting and Exposition, January 01, 2012.
Tolar, J., McGrath, J. A., Keene, D. R., Hook, K., Osborn, M. J., Riddle, M. J., Kavand, S., Hordinsky, M., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Hematopoietic and mesenchymal cell transplantation after myeloablative and non-myeloablative conditioning for recessive dystrophic and junctional epidermolysis bullosa (RDEB, JEB)", Conjoint 3rd Australasian Society for Dermatology Wound & Tissue Repair Society and 9th Australasian Society for Dermatology Research Conference 2012, January 01, 2012.
Tolar, J. "Bone Marrow Failure: Bone marrow failure in severe aplastic anemia and dyskeratosis congenita", American Society of Hematology Special Session, San Diego, California, December 11, 2011.
Tolar, J. "Mucopolysaccharidosis Type I: Cell, protein and gene therapy", SPDM (Portuguese Metabolic Disorders Society) Meeting, Porto, Portugal. November 04, 2011.
Tolar, J. "Bench to Bedside", Mini Medical School, Children’s Cancer Research Fund, Minneapolis, Minnesota, October 11, 2011.
Tolar, J. "Can Bone Marrow Cells Cure Cutaneous Diseases?", Montagna Symposium on the Biology of the Skin, Portland, Oregon, September 15, 2011.
Tolar, J. "Novel Stem Cell Transplantation Strategies for Rare Inherited Pediatric Disorders", Grand Rounds, Indiana University, Indianapolis, Indiana, September 01, 2011.
Tolar, J. "Hematogenous Cells in Skin Regeneration", Cleveland, Ohio, August 22, 2011.
Tolar, J. "Stem Cell Therapy for Rett syndrome", Rett Symposium, New York, New York, August 19, 2011.
Tolar, J. "Hematogenous Cells for Skin Extracellular Matrix Deficiency", Translational Opportunities for the Heritable Disorders of Connective Tissue, Portland, Oregon, July 11, 2011.
Tolar, J. "Stem Cell Therapies in Dermatology: A manuscript review", Department of Dermatology Journal Club, University of Minnesota, Minneapolis, Minnesota, July 06, 2011.
Tolar, J. "Bone Marrow and Cord Blood Cells for Treating Skin Collagen Deficiency in Epidermolysis Bullosa", Grand Rounds,, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, June 20, 2011.
Tolar, J. "Hematopoietic Cells for Extracellular Matrix Deficiency", CLEFT, San Francisco, California, June 10, 2011.
Tolar, J. "Epidermolysis Bullosa: Terminal desperation and terminal optimism", Department of Surgery, University of Minnesota, Minneapolis, Minnesota, June 08, 2011.
Tolar, J. "Hematopoietic and Mesenchymal Stem Cell Transplantation for Recessive Dystrophic and Junctional Epidermolysis Bullosa", 22nd World Congress of Dermatology, Seoul, Korea, Republic of. May 26, 2011.
Tolar, J. "Epidermolysis Bullosa: Rules and tools", Center for Cell and Gene Therapy Seminar, Baylor College of Medicine, Houston, Texas, May 17, 2011.
Tolar, J. "Hematopoietic and Mesenchymal Stem Cell Transplantation for Recessive Dystrophic and Junctional Epidermolysis Bullosa", Plenary session, Society for Investigative Dermatology Annual Meeting, Phoenix, Arizona, May 05, 2011.
Tolar, J. "Bone Marrow Cells for Correction of Extracellular Matrix Disorder Epidermolysis Bullosa", Pediatric Hematology/Oncology Research Seminar, Children’s Hospital Boston, Boston, Massachusetts, April 07, 2011.
Tolar, J. "Hematopoietic Transplantation: New rules and tools for congenital disorders", Pediatric Hematology/Oncology Clinical Seminar, Children’s Hospital Boston, Boston, Massachusetts, April 07, 2011.
Tolar, J. "Mucopolysaccharidosis Type I: New rules", Grand Rounds, Miami Children’s Hospital, Miami, Florida, February 22, 2011.
Tolar, J. "Grow Your Own Transplant", Third Thursday Discussion, University of Minnesota, Minneapolis, February 17, 2011.
Bertin, A. J., Tolar, J., Osborn, M., Hordinsky, M., Wagner, J. E. "Suction blister technique to evaluate skin fragility in children with recessive dystrophic epidermolysis bullosa (RDEB) treated with immunomyeloablative chemotherapy and allogeneic stem cell transplant", Minnesota Dermatological Society Spring Meeting, January 01, 2011.
Szabóová, A., Kuželka, O., Železný, F., Tolar, J. "Searching for important amino acids in DNA-binding proteins for histogram methods", 7th International Symposium on Bioinformatics Research and Applications, January 01, 2011.
Szabóová, A., Kuželka, O., Železný, F., Tolar, J. "Prediction of DNA-binding propensity of proteins using distributions of charged amino acids in primary structure", Association for Computing Machinery Conference on Bioinformatics, Computational Biology & Biomedicine, January 01, 2011.
Szabóová, A., Kuželka, O., Železný, F., Morales, S., Tolar, J. "Prediction of DNA-binding propensity of proteins by the Ball-Histogram method", 7th International Symposium on Bioinformatics Research and Applications, January 01, 2011.
Tolar, J., McGrath, J. A., Keene, D. R., Hordinsky, M., Osborn, M. J., Riddle, M. J., Bertin, A. J., Woodley, D., Chen, M., Hovnanian, A., Tamai, K., Blazar, B. R., Wagner, J. E. "Hematopoietic and mesenchymal stem cell transplantation for recessive dystrophic and junctional epidermolysis bullosa", 70th Annual Society for Investigative Dermatology Meeting, January 01, 2011.
Korthof, E. T., Van der Zalm, J., Raphael, M. F., Bresters, D., Tolar, J., Aljurf, M., Veys, P., Oneto, R., Bacigalupo, A., Peters, C., Gaspar, B., Dufour, C., Marsh, J. "Dyskeratosis Congenita: Evaluation of immune status and hematopoietic stem cell transplantation", 53rd Annual American Society of Hematology Meeting, January 01, 2011.
Osborn, M. J., Maeder, M. L., Joung, J. K., Blazar, B. R., Tolar, J. "Zinc Finger Nuclease Generation for Fanconi Anemia", American Society of Gene and Cell Therapy Annual Meeting, January 01, 2011.
Korthof, E. T., Van der Zalm, J., Bresters, D., Raphael, M. F., Tolar, J., Bekassy, A., Güngör, T., Ayas, M., Albert, M., Touzot, F., Bacigalupo, A., Fasth, A., Diaz, M., Veys, P., Cossu, F., Yabe, M., Oneto, R., Peters, C., Gaspar, H., Dufour, C., Marsh, J. "Dyskeratosis congenita: a literature and database review of immune status and stem cell transplantation data", European Group for Blood and Marrow Transplantation Meeting, January 01, 2011.
Kléma, J., Holec, M., Železný, F., Tolar, J. "Comparative evaluation of set-level techniques in microarray classification", 7th International Symposium on Bioinformatics Research and Applications, January 01, 2011.
Zhang, H., Auray-Blais, C., Young, S. P., Orchard, P., Tolar, J., Millington, D. S. "Analysis of glycosaminoglycans in cerebrospinal fluid and urine using tandem mass spectrometry: potential for therapeutic monitoring of patients with mucopolysaccharidosis", American Society for Mass Spectrometry Meeting, January 01, 2011.
Tolar, J., Deeg, H., Arai, S., Horwitz, M., Antin, J., McCarty, J., Adams, R., Eapen, M., Ewell, M., Leifer, E., Gersten, I., Carter, S., Horowitz, M., Nakamura, R., Pulsipher, M., Murphy, E., DiFronzo, N., Anderlini, P. "Fludarabine-based conditioning for allogeneic marrow transplantation from unrelated donors in severe aplastic anemia (SAA): serious and unexpected adverse events in pre-defined cyclophosphamide (CY) dose levels", 53rd Annual American Society of Hematology Meeting, January 01, 2011.
Beebe, D., George, P., Hertel, T., Tolar, J., Belani, K., Laberge, T., Wagner, J. "Anesthetic outcomes of children with epidermolysis bullosa undergoing bone marrow transplantation", International Anesthesia Research Society, January 01, 2011.
Szabóová, A., Kuželka, O., Železný, F., Tolar, J. "Searching for important amino acids in DNA-binding proteins for histogram methods", ISBRA IEEE/ACM Transactions on Computational Biology and Bioinformatics, January 01, 2011.
Webber, B., Iacovino, M., Kyba, M., Blazar, B. R., Tolar, J. "DNA methylation profile of Runx1 regulatory regions is correlated with transition from primitive to definitive hematopoietic potential in vitro and in vivo", 53rd Annual American Society of Hematology Meeting, January 01, 2011.
Raza, K., Price, A. P., Matson, A., Tolar, J., Hertz, M. I., Panoskaltsis-Mortari, A. "MSC therapy for obliterative bronchiolitis (OB)", January 01, 2011.
Moin, V., Le, S., Garban, H., Orchard, P., Tolar, J., Dickson, P. "Immune response to intrathecal enzyme therapy in Mucopolysaccharidosis I patients", Lysosomal Disease Network's WORLD Symposium 2011, January 01, 2011.
Osborn, M. J., Maeder, M. L., Joung, J. K., Blazar, B. R., Tolar, J. "Zinc finger nuclease generation for Fanconi anemia", 14th Annual American Society for Gene Therapy Meeting, January 01, 2011.
Millington, D., Zhang, H. Y., Young, S., Orchard, P., Tolar, J., Auray-Blais, C. "Analysis of glycosminoglycans in cerebrospinal fluid using tandem mass spectrometry: potential for therapeutic monitoring of patients with mucopolysaccharidoses", Lysosomal Disease Network's WORLD Symposium, January 01, 2011.
Bertin, A. J., Tolar, J., Osborn, M., Hordinsky, M., Wagner, J. E. "Suction blister technique to evaluate skin fragility in children with recessive dystrophic epidermolysis bullosa (RDEB) treated with immunomyeloablative chemotherapy and allogeneic stem cell transplant", Society for Investigative Dermatology, January 01, 2011.
Tolar, J. "Bone Marrow Failure: Genetics and pathogenetics", Session Moderator, American Society of Hematology Meeting,, Orlando, Florida, December 06, 2010.
Tolar, J. "What do You Need to Know?", Dyskeratosis Congenita Outreach Family Camp Sunshine Conference, Portland, Maine, October 01, 2010.
Tolar, J. "Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa", Grand Rounds, University of California – Davis, Sacramento, California, July 07, 2010.
Tolar, J. "Hematopoietic Cell Transplantation for Correction of Extracellular Matrix Disorder, Recessive Dystrophic Epidermolysis Bullosa", Lillehei Heart Institute Lecture, University of Minnesota, Minneapolis , Minnesota, March 17, 2010.
Tolar, J. "Finding Tomorrow’s Answers Today in Bone Marrow Transplantation at University of Minnesota Amplatz Children’s Hospital", U of M Alumni Association Statewide Speaker Tour, Plymouth Rotary, Plymouth, Minnesota, March 04, 2010.
Szabóová, A., Kuželka, O., Železný, F., Tolar, J. "Prediction of DNA-binding proteins from structural and low-resolution features", MLSB10 (Machine Learning in Systems Biology) 2010, January 01, 2010.
Tolar, J., Osborn, M. J., Maeder, M. L., Xia, L., Eide, C. R., Lees, C. J., Lund, T. C., Williams, D. A., Wagner, J. E., Joung, J. K., Blazar, B. R. "Gene editing of induced pluripotent stem cells from patients with Fanconi anemia (FA)", Fanconi Anemia Research Fund Scientific Symposium 2010, January 01, 2010.
Orchard, P. J., Basso, L., Kivisto, T., Raymond, G., Charnas, L., Nascene, D., Lund, T. C., Tolar, J. "Chitotriosidase as an inflammatory biomarker of cerebral adrenoleukodystrophy", 39th Annual Child Neurology Society Meeting, January 01, 2010.
Braunlin, E., Tolar, J., Orchard, P., Mackey-Bojack, S., Marsh, T., Schoen, F. J. "Cardiac valvular interstitial cells in MPS 1", Lysosomal Disease Network WORLD Symposium 2010, January 01, 2010.
Decanini, A., Bothun, E. D., Summers, C. G., Orchard, P. J., Tolar, J. "Outcome of penetrating keratoplasty for mucopolysaccharidoses", World Cornea Congress 2010, January 01, 2010.
Lund, T., Lidke, D., Kobs, A., Blazar, B. R., Tolar, J. "“Tasting the microenvironment”: Human bone marrow stromal cells have microenvironment chemosensory capacity via taste receptor expression", American Society of Hematology, January 01, 2010.
Boelens, J. J., Aldenhoven, M., Purtill, D., Eapen, M., DeFor, T., Wynn, R., Cavazzana-Calvo, M., Tolar, J., Prasad, V. K., Escolar, M., Gluckman, E., Orchard, P., Veys, P., Kurtzberg, J., Rocha, V. "Outcomes of transplantation using a various cell source in children with Hurler’s syndrome after myeloablative conditioning", 2010 BMT Tandem Meetings, January 01, 2010.
Eapen, M., LeRademacher, J., Deeg, H. J., Antin, J. H., Champlin, R., Carreras, J., Fay, J. W., Passweg, J. R., Tolar, J., Marsh, J., Horowitz, M. M. "Effect of stem cell source from unrelated donors on transplant outcomes in severe aplastic anemia (SAA): a comparison of unrelated bone marrow (BM) and peripheral blood progenitor cells (PBPC)", American Society of Hematology, January 01, 2010.
Hyland, K. A., Olson, E. R., Zhou, X., Tolar, J., McIvor, R. S. "Sleeping Beauty-mediated gene transfer into hematopoietic stem cells", 13th Annual American Society of Gene and Cell Therapy Meeting 2010, January 01, 2010.
Lund, T., Kobs, A., Blazar, B. R., Tolar, J. "Mesenchymal stem cells: healthy at any age", 2010 BMT Tandem Meetings, January 01, 2010.
Mynarek, M., Tolar, J., Albert, M. H., Boelens, J. J., Cowan, M. J., Escolar, M. L., Glomstein, A., Küehl, J. S., Malm, D., Orchard, P. J., Lüecke, T., Kurtzberg, J., Sykora, K. W. "Allogeneic haematopoietic stem cell transplantation in patients with alpha-mannosidosis: analysis of 13 patients", 36th Annual European Group for Blood and Marrow Transplantation Meeting, January 01, 2010.
Lund, T. C., Panoskaltsis-Mortari, A., Orchard, P., Tolar, J. "Investigation of inflammatory makers in the CSF boys with cerebral adrenoleukodystrophy", 39th Annual Child Neurology Society Meeting, January 01, 2010.
Tolar, J., Park, I. H., Xia, L., Osborn, M. J., Lund, T., Orchard, P. J., Daley, G. Q., Blazar, B. R. "Hematopoietic differentiation of personalized induced pluripotent stem cells from patients with congenital enzymopathy, Hurler syndrome", 7th Annual International Society for Stem Cell Research Annual Meeting 2010, January 01, 2010.
Szabóová, A., Kuželka, O., Železný, F., Tolar, J. "Mining frequent spatial docking patterns in zinc finger-DNA complexes", MEDICON 2010 - 7th ESBME conference 2010, January 01, 2010.
Tolar, J., Park, I. H., Xia, L., Lees, C. J., Peacock, B., Webber, B., McElmurry, R. T., Eide, C. R., Orchard, P. J., Kyba, M., Osborn, M. J., Lund, T. C., Wagner, J. E., Daley, G. Q., Blazar, B. R. "Hematopoietic differentiation of personalized induced pluripotent stem cells from patients with congenital enzymopathy, Hurler syndrome", 7th Annual International Society for Stem Cell Research, January 01, 2010.
Tolar, J., Park, I. H., Xia, L., Osborn, M. J., Lund, T., Orchard, P. J., Daley, G. Q., Blazar, B. R. "Patient-specific induced pluripotent stem cells in mucopolysaccharidosis type I", Lysosomal Disease Network WORLD Symposium 2010, January 01, 2010.
Orchard, P. J., Basso, L., Kivisto, T., Raymond, G., Charnas, L., Lund, T. C., Tolar, J. "Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy", Lysosomal Disease Network's WORLD Symposium 2010, January 01, 2010.
Price, A., Tolar, J., Dutton, J. "Panoskaltsis-Mortari A. Bioengineering the lung with iPS cells in a decellularized lung matrix bioreactor system", January 01, 2010.
Dietz, A. C., Orchard, P. J., Baker, K. S., Giller, R. H., Savage, S. A., Alter, B. P., Tolar, J. "Disease-specific hematopoietic cell transplantation: reduced intensity conditioning regimen for dyskeratosis congenita", 23rd Annual American Society of Pediatrics Hematology/Oncology Meeting, January 01, 2010.
Miller, W., Bjoraker, K. J., Chamas, L. R., Kivisto, T., Raymond, G. V., Rothman, S. M., Shapiro, E. G., Tolar, J., Ziegler, R. S., Orchard, P. J. "Hematopoietic cell transplantation for adrenoleukodystrophy: Ten year experience with 62 patients", 39th Annual Child Neurology Society Meeting, January 01, 2010.
Greising, S. M., Tolar, J., Blazar, B. R., Lowe, D. A. "Zmpste24-/- mice, a murine model of human progeria, display atrophic skeletal muscles while function is selectively preserved", The First Annual Mayo Clinic Robert and Arlene Kogod Center on Aging Conference, January 01, 2010.
Highfill, S. L., Rodriguez, P., Zhou, Q., Goetz, C. A., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J., Munn, D., Tolar, J., Ochoa, A. C., Blazar, B. R. "Bone marrow myeloid-suppressor cells (MDSC) inhibit graft versus host disease (GVHD) via an arginase-1 dependant mechanism that is upregulated by IL-13", 52nd Annual American Society of Hematology Meeting, January 01, 2010.
Miller, W. P., Rothman, S., Nascene, D., Kivisto, T., Defor, T., Lund, T., Tolar, J., Orchard, P. "Outcomes following allogeneic hematopoietic stem cell transplantation for childhood cerebral variant adrenoleukodystrophy: a modern, single institution experience", January 01, 2010.
Hyland, K. A., Olson, E. R., Zhou, X., Tolar, J., McIvor, R. S. "Sleeping Beauty-mediated therapeutic gene transfer into hematopoietic stem cells", Fanconi Anemia Research Fund Scientific Symposium 2010, January 01, 2010.
Long-Boyle, J., Huang, J., Rydholm, N., Orchard, P., Tolar, J., Jacobson, P. "Pharmacokinetics of clofarabine in patients with high risk inherited metabolic disorders undergoing reduced intensity (RI) hematopoietic cell transplantation (HCT)", January 01, 2010.
Tolar, J. "Research Advances in Epidermolysis Bullosa", Tomorrow Think of Me International EB Research Fundraiser, Toronto, Canada. December 14, 2009.
Tolar, J. "Blood and Marrow Transplant/Stem Cell Repair", 2nd Annual Institute for Engineering in Medicine Symposium, University of Minnesota, Minneapolis, Minnesota, December 10, 2009.
Tolar, J. "The Future of Fanconi Anemia Research", KATA Association’s Brave Hearts Hoot ‘N’ Holler Event, Denver, Colorado, November 21, 2009.
Tolar, J. "Transplant Outcomes in Mucopolysaccharidosis Type I", 2009 Expert Panel on the Early Diagnosis, Intervention, and Outcome of MPS I Disease, Reykjavik, Iceland. October 01, 2009.
Tolar, J. "Bone Marrow Transplantation for Epidermolysis Bullosa Therapy: Current challenges and future prospects", Conference EB2009, Vienna, Austria. September 07, 2009.
Tolar, J. "The Mucopolysaccharidosis Type I Transplant Experience", Hematopoietic Cell Transplantation in Neurometabolic Diseases Conference, Buffalo, New York, August 11, 2009.
Tolar, J. "Adult Stem Cells for Treatment of Recessive Dystrophic Epidermolysis Bullosa", 69th Annual Society for Investigative Dermatology Meeting, Montreal, Canada. May 08, 2009.
Tolar, J. "Therapy with Disease-specific Stem Cells", Pan Pacific Symposium on Stem Cell Research 2009, Taichung, Taiwan. April 12, 2009.
Tolar, J. "MSC/MAPC to Enhance Cardiac Function", 35th Annual Meeting of the EBMT, Göteborg, Sweden. April 01, 2009.
Tolar, J. "Transforming Children’s Health through Breakthrough Research and Care at the University of Minnesota", MinneCollege, University of Minnesota, Phoenix, Arizona, March 07, 2009.
Tolar, J. "Looking Ahead in Cell Therapy for Lethal Nonmalignant Diseases", Research Seminar, Princess Margaret Hospital, Toronto, Canada. February 09, 2009.
Wagner, J. E., Ishida-Yamamoto, A., McGrath, J. A., Keene, D., Hordinsky, M., Blazar, B. R., Tolar, J. "Adult stem cells for treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)", 68th Annual Society for Investigative Dermatology Meeting, January 01, 2009.
Lund, T. C., Kobs, A., Blazar, B. R., Tolar, J. "Robust mesenchymal stem cells for clinical applications can be derived from donors of any age", International Conference on Mesenchymal and Non-Hematopoietic Stem Cells 2009, January 01, 2009.
Wagner, J. E., Ishida-Yamamoto, A., McGrath, J. A., Keene, D., Hordinsky, M., Blazar, B. R., Tolar, J. "Human adult marrow stem cells ameliorate the clinical phenotype of recessive dystrophic epidermolysis bullosa (RDEB), a lethal collagen matrix skin disease", 38th Annual International Society of Stem Cell Research Meeting, January 01, 2009.
Tolar, J. "What’s New in Blood and Marrow Transplantation: Clinical and research update", Idiopathic and Congenital Marrow Failure Syndromes Series, University of Minnesota, Minneapolis, Minnesota, November 07, 2008.
Tolar, J. "What Do Epidermolysis Bullosa, Mucopolysaccharidosis and Adrenoleukodystrophy Have in Common?", University Pediatrics Foundation, St Paul., Minnesota, October 15, 2008.
Tolar, J. "Novel Therapies in Bone Marrow Transplantation", Minnesota Medical Foundation, University of Minnesota, Minneapolis, Minnesota, October 13, 2008.
Tolar, J. "Stem Cell Therapy: Science or science fiction?", Dental Science Club, St Paul, Minnesota, September 24, 2008.
Tolar, J. "Stem Cell Research at the University of Minnesota", Children’s Cancer Research Fund, Minneapolis, Minnesota, September 16, 2008.
Tolar, J. "Stem Cell Therapy for Extracellular Matrix Disorders", Stem Cell Institute Weekly Research Seminar, University of Minnesota, Minneapolis, September 16, 2008.
Tolar, J. "Overview of Stem Cell Research", Children’s Cancer Research Fund, Minneapolis, Minnesota, September 10, 2008.
Tolar, J. "Combination of Enzyme and Stem Cell Therapy for Mucopolysaccharidosis type I", Latin American Symposium MPS1, Mexico City, Mexico. August 26, 2008.
Tolar, J. "Central Nervous System Symptoms in Mucopolysaccharidosis type I: What can be done?", Latin American Symposium MPS1, Mexico City, Mexico. August 26, 2008.
Tolar, J. "How We Translate Stem Cell Research from Mice to Sick Children", Mini Medical School, Children’s Cancer Research Fund, Minneapolis, Minnesota, July 29, 2008.
Tolar, J. "Hematopoietic Cell Transplantation for Mucopolysaccharidosis type I", MPS I Co-Modality Working Group, Montreal, Canada. May 07, 2008.
Tolar, J. "Enzyme Replacement Therapy for Hurler Syndrome", Lysosomal Storage Disease Club Meeting, Toronto, Canada. May 01, 2008.
Tolar, J. "Antioxidant Neuroprotection with Hematopoietic Cell Transplantation in Cerebral Adrenoleukodystrophy", Lysosomal Disease Network/WORLD Symposium, Las Vegas, Nevada, February 15, 2008.
Tolar, J. "Early Complications after Blood and Marrow Transplantation", Grand Rounds, Lutheran General Children’s Hospital, Chicago, Illinois, January 11, 2008.
Tolar, J., Braunlin, E., Mansoor, A. M., McElmurry, R. T., Lees, C. J., Xia, L., Zhang, J., Blazar, B. R. "Adult stem cells and host immune response synergize to stimulate angiogenesis after myocardial ischemia", Scientific Session of the American Heart Association, January 01, 2008.
Tolar, J., Charnas, L., Orchard, P. J. "Antioxidant neuroprotection with hematopoietic cell transplantation in cerebral adrenoleukodystrophy", WORLD Symposium of the Lysosomal Disease Network 2008, January 01, 2008.
Tolar, J., Park, I. H., Xia, L., Osborn, M., McElmurry, R. T., Orchard, P. J., Daley, G. Q., Blazar, B. R. "Patient-specific induced pluripotent stem cells in Hurler syndrome", 50th Annual American Society of Hematology Meeting, January 01, 2008.
Tolar, J. "Host Factors in Stromal Stem Cell Transplantation", Research Seminar, Tulane University Health Sciences Center, Center for Gene Therapy, New Orleans, Louisiana, September 06, 2007.
Tolar, J. "Adult Stromal Cells and Immune System: Rules of engagement", Karolinska Institute, Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation, Stockholm, Sweden. June 08, 2007.
Tolar, J. "Novel Therapies for Fanconi Anemia", Fanconi Anemia Research Fund Regional Symposium, St Paul, Minnesota, May 19, 2007.
Tolar, J. "Hemoglobinopathies—To BMT or not to BMT?", Annual Meeting of American Society of Pediatric Hematology/Oncology and Pediatric Academic Societies Annual Meeting, Toronto, Canada. May 04, 2007.
Orchard, P. J., Eapen, M., Tolar, J., Horwitz, E., Veys, P., Fasth, F. "Hematopoietic stem cell transplantation for osteopetrosis", 12th Annual Congress of the European Hematology Association, January 01, 2007.
Tolar, J., Orchard, P. J., Key, N. S., Blazar, B. R. "Glycosaminoglycans as anticoagulants in mucopolysaccharidosis type I (MPS I)", 49th Annual American Society of Hematology, January 01, 2007.
Tolar, J., McElmurry, R. T., Bazzi, H., Xia, L., Uitto, J., Ishida-Yamamoto, A., Christiano, A. M., Blazar, B. R. "Correction of the skin defect in murine recessive dystrophic epidermolysis bullosa by bone marrow derived SLAM family receptor enriched cells", 49th Annual American Society of Hematology Meeting, January 01, 2007.
Tolar, J., Zayed, H., Xia, L., Yerich, A., Yant, S. R., Kay, M. A., Puttaraju, M., Mansfield, S. G., Wiest, D., McIvor, R. S., Blazar, B. R. "Dual system of RNA trans-splicing element and Sleeping Beauty transposon corrects DNA protein kinase mutation in severe combined immune deficiency", 12th Annual Congress of the European Hematology Association, January 01, 2007.
Tolar, J. "Risk Factors for Recurrence and Late Complications after Hematopoietic Transplantation", American Society of Hematology Annual Meeting, Orlando, Florida, December 11, 2006.
Tolar, J. "Adult Stem Cells", Children’s Cancer Research Fund, Minneapolis, Minnesota, August 22, 2006.
Tolar, J. "Enzyme Replacement Therapy Prior to and after Transplantation in MPS I", Third Annual MPS I Symposium/Current Treatment and Future Directions, Orlando, Florida, May 19, 2006.
Tolar, J. "Hematopoietic Cell Transplantation—an Update", Session Chair , American Society of Pediatric Hematology/Oncology and Pediatric Academic Societies Annual Meeting, San Francisco, California, April 29, 2006.
Tolar, J. "Adult Stem Cells—A Primer for the Clinician", American Society of Pediatric Hematology/Oncology and Pediatric Academic Societies Annual Meeting, San Francisco, California, April 29, 2006.
Tolar, J., Panoskaltsis-Mortari, A., Yerich, A. K., McElmurry, R. T., Hollander, G. A., Kren, B. T., Steer, C. J., Blazar, B. R. "Induction of endogenous repair mechanisms by single-stranded DNA oligonucleotide therapy for correction of the DNA-PK mutation in murine severe combined immune deficiency", 48th Annual American Society of Hematology Meeting, January 01, 2006.
Tolar, J., Wang, X., Braunlin, E., McElmurry, R. T., Nakamura, Y., Xia, L., Zhang, J., Bell, J., Panoskaltsis-Mortar, A., Zhang, J. Y., Blazar, B. R. "Host immune response is critical for the beneficial effect of adult stem cells after myocardial ischemia", Scientific Session of the American Heart Association Meeting, January 01, 2006.
Tolar, J., MacMillan, M., Hirsch, B., Eide, C., Levran, O., Hannenberg, H., Blazar, B. R., Auerback, A. D., Wagner, J. "Hematopoietic stem cell mosaicism in Fanconi anemia", Fanconi Anemia Research Fund Scientific Symposium 2006, January 01, 2006.
Tolar, J. "Non-viral Transfer of Human FA-C gene into Neonatal Fanconi Anemia C Mice", Fanconi Anemia Scientific Symposium, Geneva, Switzerland. October 01, 2005.
Tolar, J. "Multipotent Adult Progenitor Cells Improve Aortic Insufficiency in Murine Model of Hurler Syndrome", Child Health Research Centers Annual Retreat, Salt Lake City, Utah, September 17, 2005.
Tolar, J. "Healing Injured Tissues with Adult Stem Cells", University Pediatrics Foundation, Minneapolis, July 10, 2005.
Tolar, J. "Gene Therapy—A Primer for the Clinician", Session Chair at the American Society of Pediatric Hematology/Oncology and Pediatric Academic Societies Annual Meeting, Washington, District of Columbia, May 16, 2005.
Tolar, J., Yerich, A. K., Eide, C., Wagner, J. E., Kacett, P. B., Grompe, M., Blazar, B. R. "Non-viral transfer of human FA-C gene into neonatal Fanconi anemia C mice", Fanconi Anemia Research Fund Scientific Symposium 2005, January 01, 2005.
Tolar, J., Braunlin, E., Berry, J., McElmurry, R. T., Bell, S., Clarke, L., Verfaillie, C., Blazar, B. R. "Multipotent adult progenitor cells improve aortic insufficiency in murine model of Hurler syndrome", Child Health Research Centers Meeting 2005, January 01, 2005.
Tolar, J. "MAPC Reduce GAG Accumulation in a Murine Model of Hurler Syndrome", Lysosomal Disease Network/WORLD Symposium, Minneapolis, Minnesota, May 13, 2004.
Tolar, J. "Idiopathic Acquired Aplastic Anemia", Non-Immune Cytopenias Workshop, American Society of Pediatric Hematology/Oncology and Pediatric Academic Societies Annual Meeting, San Francisco, California, April 30, 2004.
Tolar, J., Bell, S., McElmurry, R. T., Xia, L., McIvor, S. R., Yant, S. R., Kay, M. A., Contag, C. H., Verfaillie, C. M., Blazar, B. R. "Real-time in vivo biodistribution of multipotent adult progenitor cells (MAPC): role of the immune system in MAPC resistance in non-transplanted and bone marrow transplanted mice", 46th Annual American Society of Hematology Meeting, January 01, 2004.
Tolar, J., Clarke, L., Jiang, Y., McElmurry, R. T., Vengco, I., Yerich, A., Peters, C., Verfaillie, C. M., Blazar, B. R. "Multipotent adult progenitor cells reduce glycosaminoglycan accumulation in a murine model of Hurler Syndrome", Child Health Research Center Meeting, January 01, 2004.
Tolar, J., Clarke, L. A., Jiang, Y., McElmurry, R. T., Vengco, I., Yerich, A., Peters, C., Verfaillie, C. M., Blazar, B. R. "Multipotent adult progenitor cells (MAPCs) reduce glycosaminoglycan accumulation in murine model of Hurler Syndrome, MPS 1H", WORLD Symposium of the Lysosomal Disease Network, January 01, 2004.
Tolar, J., Jiang, Y., McElmurry, R. T., Jahagirdar, B., Blackstad, M., Verfaillie, C. M., Blazar, B. R. "The in utero transfer of murine multipotent adult progenitor cells (MAPCs) results in brain and liver differentiation", 43rd American Society of Hematology Meeting, January 01, 2001.
Tolar, J., Ostrow, R., McGlennen, R., Lemke, T., Tobolt, D., Faras, A. "Biological characterization of naturally occurring mutations in an oncogenic variant of human papillomavirus type 11", International Papillomavirus Meeting, January 01, 1996.
Grants and Patents

Grants and Patents

Patents

TALEN-Based Gene Correction. Issued: 2016
MAPC Administration for the Treatment of Lysosomal Storage Disorders. Issued: 2011
Transferrin Fusion Gene/Protein for Delivery of Therapeutic Agents across the Blood Brain Barrier and into the Central Nervous System. Issued: 2007
Compositions and Methods for the Treatment of Lysosomal Storage Disorders. Issued: 2003
Use of NK Cell Inhibition to Facilitate Persistence of Engrafted MHC-I-Negative Cells.
DNA Repair Using CRISPR/Cas9 System, OTC application .
Derivation of Human T-(Progenitor) Cells from Human T-Cells Derived Induced Pluripotent Stem Cells (T-iPSCs), OTC application .